SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001169245-22-000003
Filing Date
2022-01-14
Accepted
2022-01-14 17:04:23
Documents
6
Effectiveness Date
2022-01-14

Document Format Files

Seq Description Document Type Size
1 S-8 s-8coverpagephasebiox2022s.htm S-8 77162
2 EX-5.1 ex51phas-2022evergreenandi.htm EX-5.1 12862
3 EX-23.1 ex231c-3phassx8consent_upd.htm EX-23.1 2799
4 EX-99.3 ex993phasebio-2022induceme.htm EX-99.3 378554
5 image_0.jpg GRAPHIC 161
6 image_1.jpg GRAPHIC 8359
  Complete submission text file 0001169245-22-000003.txt   484551
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-262185 | Film No.: 22532559
SIC: 2834 Pharmaceutical Preparations